Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione s-transferase in primary cultured rat cerebral cortical cells

Neuroscience Letters

Volumn 455, Issue 1, 2009, Pages 70-73

  Bakare, Adedolapo ^b   Shao, Li ^a   Cui, Jie ^c   Young, L Trevor ^a   Wang, Jun Feng ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bipolar disorder; Carbamazepine; Glutathione s transferase; Lamotrigine; Olanzapine; Oxidative stress

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE M1; LAMOTRIGINE; MOOD STABILIZER; OLANZAPINE;

ARTICLE; BIPOLAR DISORDER; BRAIN CELL; BRAIN CORTEX; CELL PROTECTION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; IMMUNOBLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANIMALS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CELLS, CULTURED; CEREBRAL CORTEX; GLUTATHIONE TRANSFERASE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TRIAZINES;

EID: 63449119556     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.022     Document Type: Article

References (26)

1. Bashkatova V., Narkevich V., Vitskova G., and Vanin A. The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog. Neuropsychopharmacol. Biol. Psychiat. 27 (2003) 487-492
2. Berk M., and Berk L. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events. Ann. Clin. Psychiat. 15 (2003) 217-224
3. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., Anderson-Hunt M., and Bush A.I. N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol. Psychiat. 64 (2008) 468-475
4. Calabrese J.R., Vieta E., and Shelton M.D. Latest maintenance data on lamotrigine in bipolar disorder. Eur. Neuropsychopharmacol. 13 Suppl. 2 (2003) S57-S66
5. Cho S.G., Lee Y.H., Park H.S., Ryoo K., Kang K.W., Park J., Eom S.J., Kim M.J., Chang T.S., Choi S.Y., Shim J., Kim Y., Dong M.S., Lee M.J., Kim S.G., Ichijo H., and Choi E.J. Glutathione s-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276 (2001) 12749-12755
6. Eren I., Naziroǧlu M., and Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem. Res. 32 (2007) 1188-1195
7. Goa K.L., Ross S.R., and Chrisp P. Lamotrigine, a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46 (1993) 152-176
8. Hayes J.D., and Strange R.C. Glutathione s-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
9. Kim Y.J., Ko H.H., Han E.S., and Lee C.S. Lamotrigine inhibition of rotenone or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death. Brain Res. Bull. 71 (2007) 633-640
10. Lees G., and Leach M.J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex. Brain Res. 612 (1993) 190-199
11. Lieberman D.Z., and Goodwin F.K. Use of olanzapine in the treatment of bipolar I disorder. Expert Rev. Neurother. 4 (2004) 759-767
12. Pillai A., Parikh V., Terry A.V., and Mahadik S.P. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J. Psychiat. Res. 41 (2007) 372-386
13. Rowe M.K., and Chuang D.M. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev. Mol. Med. 6 (2004) 1-18
14. Seeman P. Atypical antipsychotics: mechanism of action. Can. J. Psychiat. 47 (2002) 27-38
15. Shao L., Cui J., Young L.T., and Wang J.F. The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 151 (2008) 518-524
16. Solano F., Hearing V.J., and García-Borrón J.C. Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification. Neurotox. Res. 1 (2000) 153-169
17. Strange R.C., Spiteri M.A., Ramachandran S., and Fryer A.A. Glutathione-s-transferase family of enzymes. Mutat. Res. 482 (2001) 21-26
18. Townsend D.M., and Tew K.D. The role of glutathione-s-transferase in anti-cancer drug resistance. Oncogene 22 (2003) 7369-7375
19. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., and Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 4 (2002) 405-414
20. Vajda F.J. Valproate and neuroprotection. J. Clin. Neurosci. 9 (2002) 508-514
21. Wang H., Xu H., Dyck L.E., and Li X.M. Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide (25-35)-induced oxidative stress and the ensuing apoptosis. J. Neurosci. Res. 81 (2005) 572-580
22. Wang J.F. Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Can. J. Psychiat. 52 (2007) 753-762 (Review)
23. Wang J.F., Shao L., Sun X., and Young L.T. Glutathione s-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J. Neurochem. 88 (2004) 1477-1484
24. J.F. Wang, L. Shao, X. Sun, L.T. Young, Increased oxidative stress in anterior cingulate cortex of subjects with bipolar disorder and schizophrenia, Bipolar Disord., in press.
25. Wang S.J., Sihra T.S., and Gean P.W. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 12 (2001) 2255-2258
26. Wei Z., Bai O., Richardson J.S., Mousseau D.D., and Li X.M. Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. J. Neurosci. Res. 73 (2003) 364-368